home / stock / crxt / crxt quote
Last: | $0.099 |
---|---|
Change Percent: | -66.1% |
Open: | $0.136 |
Close: | $0.292 |
High: | $0.14 |
Low: | $0.095 |
Volume: | 13,035,456 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.099 | $0.136 | $0.292 | $0.14 | $0.095 | 13,035,456 | 08-30-2022 |
$0.157 | $0.1377 | $0.292 | $0.16 | $0.1325 | 9,234,563 | 08-29-2022 |
$0.2038 | $0.21 | $0.292 | $0.2689 | $0.2011 | 9,725,539 | 08-26-2022 |
$0.2166 | $0.1973 | $0.292 | $0.2297 | $0.19 | 6,070,412 | 08-25-2022 |
$0.197 | $0.1851 | $0.292 | $0.1973 | $0.18 | 2,080,833 | 08-24-2022 |
$0.1831 | $0.18 | $0.292 | $0.185 | $0.172 | 2,034,456 | 08-23-2022 |
$0.189 | $0.2112 | $0.292 | $0.2138 | $0.1729 | 6,066,552 | 08-22-2022 |
$0.2062 | $0.238 | $0.292 | $0.2398 | $0.1984 | 7,559,500 | 08-19-2022 |
$0.2832 | $0.2833 | $0.292 | $0.298 | $0.262 | 1,192,643 | 08-18-2022 |
$0.2833 | $0.305 | $0.292 | $0.31 | $0.28 | 978,839 | 08-17-2022 |
$0.2945 | $0.3349 | $0.292 | $0.3372 | $0.2945 | 2,019,130 | 08-16-2022 |
$0.347 | $0.33 | $0.292 | $0.3489 | $0.3179 | 613,287 | 08-15-2022 |
$0.3225 | $0.32 | $0.292 | $0.33 | $0.3121 | 858,799 | 08-12-2022 |
$0.3114 | $0.3193 | $0.292 | $0.3199 | $0.3091 | 1,107,391 | 08-11-2022 |
$0.3248 | $0.3255 | $0.292 | $0.3447 | $0.32 | 2,244,870 | 08-10-2022 |
$0.3155 | $0.31 | $0.292 | $0.3383 | $0.3 | 3,463,428 | 08-09-2022 |
$0.308 | $0.2991 | $0.292 | $0.308 | $0.295 | 917,305 | 08-08-2022 |
$0.3033 | $0.29 | $0.292 | $0.3173 | $0.29 | 941,668 | 08-05-2022 |
$0.2929 | $0.283 | $0.292 | $0.2967 | $0.276 | 1,071,729 | 08-04-2022 |
$0.2834 | $0.29 | $0.292 | $0.293 | $0.2828 | 1,008,463 | 08-03-2022 |
News, Short Squeeze, Breakout and More Instantly...
Clarus Therapeutics Holdings Inc. Company Name:
CRXT Stock Symbol:
NASDAQ Market:
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXTQ), a pharmaceutical company dedicated to providing solutions to un...
NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen therapies, announced today that it, together with its wholly-owned subsidiary ...